MET and non-small cell lung carcinoma: Several genes, including bromodomain PHD finger transcription factor (BPTF) [22], serum thrombospondin-2 [23], CTAPIII/CXCL7 [24], c-MET [25], and so on, have been reported to be biomarkers of NSCLC.